Log in to save to my catalogue

BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytoto...

BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytoto...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7297141

BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications

About this item

Full title

BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2020-01, Vol.34 (1), p.210-223

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The purpose of these studies was to develop and characterize B-cell maturation antigen (BCMA)-specific peptide-encapsulated nanoparticle formulations to efficiently evoke BCMA-specific CD8
+
cytotoxic T lymphocytes (CTL) with poly-functional immune activities against multiple myeloma (MM). Heteroclitic BCMA
72−80
[
Y
LMFLLRKI] pep...

Alternative Titles

Full title

BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7297141

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7297141

Other Identifiers

ISSN

0887-6924,1476-5551

E-ISSN

1476-5551

DOI

10.1038/s41375-019-0540-7

How to access this item